Drug Approval | January 11, 2024
Unichem receives ANDA approval for Doxazosin Tablets
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
The company has received five final approvals
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Loteprednol Etabonate Ophthalmic Suspension, 0.2%, is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis
The product is expected to be launched in December 2023
US FDA approval based on NEURO-TTRansform Phase III results
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Sitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus
Lacosamide is indicated to treat partial-onset seizures
Subscribe To Our Newsletter & Stay Updated
